|
|
Article: N-Gene Research Laboratories, Inc. Receives $3.0 Million in Funding from CORVINUS RT.
- Article from:
- PR Newswire
- Article date:
- April 6, 2006
CopyrightCOPYRIGHT 2006 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK, and BUDAPEST, Hungary, April 6 /PRNewswire/ -- N-Gene Research Laboratories, Inc., a privately held biopharmaceutical company developing products to treat insulin-resistance syndrome, announced today that it is receiving a US$3.0 million investment in a Series B/1 round from CORVINUS Venture Capital Funds Management, Ltd., a fund established in October 2005 to invest into Hungarian high tech initiatives.
Proceeds from the offering will be used to fund continued clinical development of N-Gene's lead product candidates, including BGP-15, a small molecule insulin sensitizer that has completed Phase II clinical trials in Hungary, and NG-SUN, a ...